Edition:
India

Ablynx NV (ABLX.OQ)

ABLX.OQ on NASDAQ Stock Exchange Global Select Market

41.63USD
19 Jan 2018
Change (% chg)

$-0.72 (-1.70%)
Prev Close
$42.35
Open
$42.22
Day's High
$42.37
Day's Low
$41.33
Volume
38,032
Avg. Vol
--
52-wk High
$45.58
52-wk Low
$17.75

Chart for

About

Ablynx NV is a Belgium-based biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx NV has more than 30 proprietary and... (more)

Overall

Beta: 1.59
Market Cap(Mil.): €987.62
Shares Outstanding(Mil.): 61.42
Dividend: --
Yield (%): --

Financials

Deals of the day-Mergers and acquisitions

Jan 18 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday:

19 Jan 2018

UPDATE 2-European shares edge higher as cyclicals back in favour

* Financials, tech and materials lead rise (Recasts, adds detail and quote, updates prices at close)

18 Jan 2018

LIVE MARKETS-Closing snapshot: European shares end session with modest rise

* European shares end slightly higher * Tech leads gains * Utilities among biggest fallers Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net CLOSING SNAPSHOT: EUROPEAN SHARES END SESSION WITH MODEST RISE (1724 GMT) As cyclical stocks make a

18 Jan 2018

LIVE MARKETS-"Too early to get excited" about volatility

* European shares dip * Tech leads gains * Utilities suffer most Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net "TOO EARLY TO GET EXCITED" ABOUT VOLATILITY (1615 GMT) With the Vix now trading above 12 and a growing number of str

18 Jan 2018

LIVE MARKETS-Has the UK market "cemented" its rotation into cyclicals?

* European shares dip * Tech leads gains * Utilities suffer most Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net HAS THE UK MARKET "CEMENTED" ITS ROTATION INTO CYCLICALS? (1547 GMT) For Man Group, the answer is a clear "yes". "In

18 Jan 2018

LIVE MARKETS-Be selective on European banks

* European shares dip * Tech leads gains * Utilities suffer most Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net BE SELECTIVE ON EUROPEAN BANKS (1511 GMT) The cyclical rally that has shaped stock trading in January has seen banks as pr

18 Jan 2018

LIVE MARKETS-Economic boom seen powering European cyclical stocks

* European shares rise slightly * Tech leads gains * Real estate suffers most Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net ECONOMIC BOOM SEEN POWERING EUROPEAN CYCLICAL STOCKS (1441 GMT) The BlackRock Investment Institute joins in the p

18 Jan 2018

LIVE MARKETS-Half-session snapshot: all quiet in Europe

* European shares ease gains * FTSE retreats * Tech leads gains * Real estate suffers most Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net HALF-SESSION SNAPSHOT: ALL QUIET IN EUROPE (1316 GMT) European shares have come off highs with t

18 Jan 2018

UPDATE 1-Largest Ablynx investor would consider improved Novo Nordisk bid

BRUSSELS, Jan 18 The largest shareholder in Belgian biotech group Ablynx regards the 2.6 billion euro ($3.2 billion) offer made by Denmark's Novo Nordisk as too low but would be willing to consider a higher figure.

18 Jan 2018

LIVE MARKETS-Finding opportunities among the disrupted

* European shares edge higher * FTSE retreats * Tech leads gains Jan 18 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net FINDING OPPORTUNITIES AMONG THE DISRUPTED (1215 GMT) Much has been made of the wave of disruption impacting almost every secto

18 Jan 2018

Earnings vs. Estimates